These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10857971

  • 1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J, Markkanen A, Kärkkäinen P, Pihlajamäki J, Kekäläinen P, Mykkänen L, Kuusisto J, Karhapää P, Niskanen L, Laakso M.
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [Abstract] [Full Text] [Related]

  • 2. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T, Echwald SM, Hansen L, Møller AM, Almind K, Clausen JO, Urhammer SA, Inoue H, Ferrer J, Bryan J, Aguilar-Bryan L, Permutt MA, Pedersen O.
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [Abstract] [Full Text] [Related]

  • 3. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF, Hani EH, Beressi N, Robert JJ, Bresson JL, Froguel P, Velho G.
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [Abstract] [Full Text] [Related]

  • 4. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ.
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [Abstract] [Full Text] [Related]

  • 5. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM, Dekker JM, van Haeften TW, Ruige JB, Stehouwer CD, Erkelens DW, Heine RJ, Maassen JA.
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [Abstract] [Full Text] [Related]

  • 6. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.
    Ohta Y, Tanizawa Y, Inoue H, Hosaka T, Ueda K, Matsutani A, Repunte VP, Yamada M, Kurachi Y, Bryan J, Aguilar-Bryan L, Permutt MA, Oka Y.
    Diabetes; 1998 Mar; 47(3):476-81. PubMed ID: 9519757
    [Abstract] [Full Text] [Related]

  • 7. [Study on association between gestational diabetes mellitus and sulfonylurea receptor-1 gene polymorphism].
    Niu XM, Yang H, Zhang HY, Li NJ, Qi XM, Chang Y, Chang Z, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):159-63. PubMed ID: 15840308
    [Abstract] [Full Text] [Related]

  • 8. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
    Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC, UK Prospective Diabetes Study (UKPDS 53).
    Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
    [Abstract] [Full Text] [Related]

  • 9. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.
    Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R, Warren-Perry M, Zhang Y, Millns H, Turner R, Province M, Bryan J, Permutt MA, Aguilar-Bryan L.
    Diabetes; 1996 Jun; 45(6):825-31. PubMed ID: 8635661
    [Abstract] [Full Text] [Related]

  • 10. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
    Hansen T, Ambye L, Grarup N, Hansen L, Echwald SM, Ferrer J, Pedersen O.
    Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
    [Abstract] [Full Text] [Related]

  • 11. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus.
    Ishiyama-Shigemoto S, Yamada K, Yuan X, Koyama W, Nonaka K.
    Diabet Med; 1998 Oct; 15(10):826-9. PubMed ID: 9796882
    [Abstract] [Full Text] [Related]

  • 12. A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancy.
    Krugluger W, Festa A, Shnawa N, Bucher J, Boltz-Nitulescu G, Schernthaner G, Hopmeier P.
    J Inherit Metab Dis; 2000 Nov; 23(7):705-12. PubMed ID: 11117432
    [Abstract] [Full Text] [Related]

  • 13. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
    Gonen MS, Arikoglu H, Erkoc Kaya D, Ozdemir H, Ipekci SH, Arslan A, Kayis SA, Gogebakan B.
    Arch Med Res; 2012 May; 43(4):317-23. PubMed ID: 22704848
    [Abstract] [Full Text] [Related]

  • 14. The common C49620T polymorphism in the sulfonylurea receptor gene SUR1 (ABCC8) in patients with gestational diabetes and subsequent glucose metabolism abnormalities.
    Molęda P, Bińczak-Kuleta A, Homa K, Safranow K, Celewicz Z, Syrenicz A, Stefański A, Fronczyk A, Majkowska L.
    Exp Diabetes Res; 2012 May; 2012():712617. PubMed ID: 22927833
    [Abstract] [Full Text] [Related]

  • 15. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
    Owecki M, Horst-Sikorska W, Kaczmarek M, Słomski R, Sowiński J.
    Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
    [Abstract] [Full Text] [Related]

  • 16. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
    Zychma MJ, Gumprecht J, Strojek K, Grzeszczak W, Moczulski D, Trautsolt W, Karasek D.
    Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
    [Abstract] [Full Text] [Related]

  • 17. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians.
    Reis AF, Ye WZ, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G.
    Hum Genet; 2000 Aug; 107(2):138-44. PubMed ID: 11030411
    [Abstract] [Full Text] [Related]

  • 18. Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
    Reis AF, Velho G.
    Diabetes Metab; 2002 Feb; 28(1):14-9. PubMed ID: 11938023
    [Abstract] [Full Text] [Related]

  • 19. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene.
    Weisnagel SJ, Rankinen T, Nadeau A, Rao DC, Chagnon YC, Pérusse L, Bouchard C.
    Diabetes; 2001 Mar; 50(3):697-702. PubMed ID: 11246895
    [Abstract] [Full Text] [Related]

  • 20. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H, Vauhkonen I, Komulainen J, Niskanen L, Otonkoski T, Laakso M.
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.